Clinical Trial Update: Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating how the microbiome affects insulin sensitivity; study completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Insulin Sensitivity Disorders
• Type 2 Diabetes Mellitus

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Insulin Sensitivity | Phase 2 | Status: COMPLETED | Results posted: 2021-10-15